Solid Power Reports First Quarter 2026 Results
Recent Business Highlights
- Completed site acceptance testing for the SK On pilot cell line.
- Began facilities construction and completed factory acceptance testing of all key equipment for our continuous manufacturing pilot line for sulfide electrolyte production; commissioning remains on track for the end of 2026.
- Provided Samsung SDI with electrolyte under the Joint Evaluation Agreement with Samsung SDI and BMW and continued sampling to other customers.
-
Continued to explore potential partners for commercial-scale electrolyte production in the
Republic of Korea . -
Maintained financial discipline and completed a
$130 million registered direct offering.
“Completion of site acceptance testing marks an important moment in our partnership with SK On and the final milestone under the line installation agreement,” said
First Quarter 2026 Financial Highlights
Operating expenses were
Balance Sheet and Liquidity
Solid Power’s liquidity position remains strong. Total liquidity as of
|
(in thousands) |
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
31,509 |
|
$ |
21,607 |
|
Available-for-sale securities |
|
|
403,763 |
|
|
314,843 |
|
Total liquidity |
|
$ |
435,272 |
|
$ |
336,450 |
As of
First quarter 2026 capital expenditures totaled
Webcast and Conference Call
The call may be accessed through a live audio webcast on Solid Power’s Investor Relations website at www.solidpowerbattery.com/investor-relations. An audio replay will be available at the same location.
About
Forward-Looking Statements
All statements other than statements of present or historical fact contained herein are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including Solid Power’s or its management team’s expectations, objectives, beliefs, intentions or strategies regarding the future. When used herein, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” “plan,” “outlook,” “seek,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements include our financial guidance for 2026; our future financial performance, strategy, expansion plans, including plans related to the expansion of our electrolyte production capabilities, market opportunity, operations, and operating results; estimated revenues or losses; projected costs; future prospects; and plans and objectives of management. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law,
|
|
||||||||
|
Condensed Consolidated Balance Sheets |
||||||||
|
(in thousands, except par value and number of shares) |
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
(Unaudited) |
|
|
||||
|
Assets |
|
|
|
|
|
|
||
|
Current Assets |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
31,509 |
|
|
$ |
21,607 |
|
|
Marketable securities |
|
|
223,899 |
|
|
|
229,177 |
|
|
Accounts receivable |
|
|
4,221 |
|
|
|
2,155 |
|
|
Contract assets |
|
|
8,480 |
|
|
|
7,490 |
|
|
Prepaid expenses and other current assets |
|
|
6,634 |
|
|
|
6,998 |
|
|
Total current assets |
|
|
274,743 |
|
|
|
267,427 |
|
|
Long-Term Assets |
|
|
|
|
|
|
||
|
Property, plant and equipment, net |
|
|
84,939 |
|
|
|
86,318 |
|
|
Right-of-use operating lease assets, net |
|
|
6,491 |
|
|
|
6,727 |
|
|
Investments |
|
|
181,000 |
|
|
|
86,997 |
|
|
Intangible assets, net |
|
|
2,161 |
|
|
|
2,166 |
|
|
Other assets |
|
|
962 |
|
|
|
1,059 |
|
|
Loan receivable from equity method investee |
|
|
4,432 |
|
|
|
4,398 |
|
|
Total long-term assets |
|
|
279,985 |
|
|
|
187,665 |
|
|
Total assets |
|
$ |
554,728 |
|
|
$ |
455,092 |
|
|
Liabilities, Mezzanine Equity and Stockholders’ Equity |
|
|
|
|
|
|
||
|
Current Liabilities |
|
|
|
|
|
|
||
|
Accounts payable and other accrued liabilities |
|
|
12,488 |
|
|
|
8,521 |
|
|
Deferred revenue |
|
|
198 |
|
|
|
198 |
|
|
Deferred revenue from related parties |
|
|
172 |
|
|
|
172 |
|
|
Accrued compensation |
|
|
3,308 |
|
|
|
7,043 |
|
|
Operating lease liabilities |
|
|
886 |
|
|
|
861 |
|
|
Total current liabilities |
|
|
17,052 |
|
|
|
16,795 |
|
|
Long-Term Liabilities |
|
|
|
|
|
|
||
|
Warrant liabilities |
|
|
4,240 |
|
|
|
13,881 |
|
|
Operating lease liabilities |
|
|
6,877 |
|
|
|
7,129 |
|
|
Other liabilities |
|
|
1,102 |
|
|
|
1,113 |
|
|
Total long-term liabilities |
|
|
12,219 |
|
|
|
22,123 |
|
|
Total liabilities |
|
|
29,271 |
|
|
|
38,918 |
|
|
Mezzanine Equity |
|
|
|
|
|
|
||
|
Mezzanine Equity |
|
|
401 |
|
|
|
470 |
|
|
Stockholders’ Equity |
|
|
|
|
|
|
||
|
Common Stock, |
|
|
22 |
|
|
|
20 |
|
|
Additional paid-in capital |
|
|
813,922 |
|
|
|
690,234 |
|
|
Accumulated deficit |
|
|
(287,835 |
) |
|
|
(274,904 |
) |
|
Accumulated other comprehensive income |
|
|
(1,053 |
) |
|
|
354 |
|
|
Total stockholders’ equity |
|
|
525,056 |
|
|
|
415,704 |
|
|
Total liabilities, mezzanine equity and stockholders’ equity |
|
$ |
554,728 |
|
|
$ |
455,092 |
|
|
|
||||||||
|
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) |
||||||||
|
(in thousands, except number of shares and per share amounts) |
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
Three Months Ended |
||||||
|
|
|
2026 |
|
2025 |
||||
|
Revenues and Grant Income |
|
|
|
|
|
|
||
|
Revenue |
|
$ |
2,105 |
|
|
$ |
5,125 |
|
|
Grant income |
|
|
968 |
|
|
|
891 |
|
|
Total revenue and grant income |
|
|
3,073 |
|
|
|
6,016 |
|
|
Operating Expenses |
|
|
|
|
|
|
||
|
Direct costs |
|
|
3,548 |
|
|
|
2,696 |
|
|
Research and development |
|
|
17,749 |
|
|
|
19,022 |
|
|
Selling, general and administrative |
|
|
8,122 |
|
|
|
8,327 |
|
|
Total operating expenses |
|
|
29,419 |
|
|
|
30,045 |
|
|
Operating Loss |
|
|
(26,346 |
) |
|
|
(24,029 |
) |
|
Nonoperating Income and Expense |
|
|
|
|
|
|
||
|
Interest income |
|
|
4,012 |
|
|
|
3,599 |
|
|
Change in fair value of warrant liabilities |
|
|
9,642 |
|
|
|
5,879 |
|
|
Interest expense |
|
|
(197 |
) |
|
|
(8 |
) |
|
Other income (expense) |
|
|
17 |
|
|
|
(522 |
) |
|
Total nonoperating income and expense |
|
|
13,474 |
|
|
|
8,948 |
|
|
Pretax Loss |
|
$ |
(12,872 |
) |
|
$ |
(15,081 |
) |
|
Income tax expense |
|
|
84 |
|
|
|
— |
|
|
Share of net loss of equity method investee |
|
|
72 |
|
|
|
70 |
|
|
Net Loss Attributable to Common Stockholders |
|
$ |
(13,028 |
) |
|
$ |
(15,151 |
) |
|
Other Comprehensive Income (Loss) |
|
|
(1,407 |
) |
|
|
173 |
|
|
Comprehensive Loss Attributable to Common Stockholders |
|
$ |
(14,435 |
) |
|
$ |
(14,978 |
) |
|
Basic and diluted loss per share |
|
$ |
(0.06 |
) |
|
$ |
(0.08 |
) |
|
Weighted average shares outstanding – basic and diluted |
|
|
217,299,594 |
|
|
|
181,404,557 |
|
|
|
|
|
|
|
|
|
||
|
|
||||||||
|
Consolidated Statements of Cash Flows (Unaudited) |
||||||||
|
(in thousands, except par value, share amounts, and per share amounts) |
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
Three Months Ended |
||||||
|
|
|
2026 |
|
2025 |
||||
|
Cash Flows from Operating Activities |
|
|
|
|
|
|
||
|
Net loss |
|
$ |
(13,028 |
) |
|
$ |
(15,151 |
) |
|
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: |
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
|
4,733 |
|
|
|
4,541 |
|
|
Amortization of right-of-use assets |
|
|
303 |
|
|
|
322 |
|
|
Loss on sales of property, plant and equipment, net |
|
|
181 |
|
|
|
444 |
|
|
Share of net loss of equity method investee |
|
|
72 |
|
|
|
70 |
|
|
Stock-based compensation expense |
|
|
2,706 |
|
|
|
1,830 |
|
|
Change in fair value of warrant liabilities |
|
|
(9,642 |
) |
|
|
(5,879 |
) |
|
Accretion of discounts on other long-term liabilities |
|
|
17 |
|
|
|
16 |
|
|
Accretion of loan receivable from equity method investee |
|
|
(35 |
) |
|
|
(31 |
) |
|
Amortization of premiums and accretion of discounts on available-for-sale securities |
|
|
(804 |
) |
|
|
(1,359 |
) |
|
Loss on change in assessment of finance lease purchase options |
|
|
— |
|
|
|
84 |
|
|
Change in operating assets and liabilities that provided (used) cash and cash equivalents: |
|
|
|
|
|
|
||
|
Accounts receivable |
|
|
(1,519 |
) |
|
|
(445 |
) |
|
Contract assets |
|
|
(991 |
) |
|
|
— |
|
|
Prepaid expenses and other current assets and other assets |
|
|
1,642 |
|
|
|
(506 |
) |
|
Accounts payable and other accrued liabilities |
|
|
1,574 |
|
|
|
(2,445 |
) |
|
Deferred revenue |
|
|
— |
|
|
|
(3,150 |
) |
|
Accrued compensation |
|
|
(3,735 |
) |
|
|
(4,436 |
) |
|
Operating lease liabilities |
|
|
(227 |
) |
|
|
(196 |
) |
|
Net cash and cash equivalents used in operating activities |
|
|
(18,753 |
) |
|
|
(26,291 |
) |
|
Cash Flows from Investing Activities |
|
|
|
|
|
|
||
|
Purchases of property, plant and equipment, net |
|
|
(1,671 |
) |
|
|
(2,354 |
) |
|
Purchases of available-for-sale securities |
|
|
(185,237 |
) |
|
|
(41,825 |
) |
|
Proceeds from sales of available-for-sale securities |
|
|
94,620 |
|
|
|
75,156 |
|
|
Purchases of intangible assets |
|
|
— |
|
|
|
(478 |
) |
|
Net cash and cash equivalents (used in) provided by investing activities |
|
|
(92,288 |
) |
|
|
30,499 |
|
|
Cash Flows from Financing Activities |
|
|
|
|
|
|
||
|
Proceeds from exercise of stock options |
|
|
6 |
|
|
|
181 |
|
|
Cash paid for withholding of employee taxes related to stock-based compensation |
|
|
(358 |
) |
|
|
(261 |
) |
|
Payments on finance lease liabilities |
|
|
(52 |
) |
|
|
(87 |
) |
|
Proceeds from the registered direct offering, net of fees |
|
|
121,347 |
|
|
|
— |
|
|
Net cash and cash equivalents provided by (used in) financing activities |
|
|
120,943 |
|
|
|
(167 |
) |
|
|
|
|
|
|
|
|
||
|
Net increase in cash and cash equivalents |
|
|
9,902 |
|
|
|
4,041 |
|
|
Cash and cash equivalents at beginning of period |
|
|
21,607 |
|
|
|
25,413 |
|
|
Cash and cash equivalents at end of period |
|
|
31,509 |
|
|
|
29,454 |
|
|
|
|
|
|
|
|
|
||
|
Supplemental information |
|
|
|
|
|
|
||
|
Cash paid for interest |
|
$ |
4 |
|
|
$ |
8 |
|
|
Accrued capital expenditures |
|
|
2,509 |
|
|
|
1,689 |
|
|
Unpaid reimbursements on capital expenditures |
|
|
547 |
|
|
|
382 |
|
|
Accrued direct offering costs for the issuance of common stock |
|
|
11 |
|
|
|
— |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260505214730/en/
investors@solidpowerbattery.com
press@solidpowerbattery.com
Source: